Literaturverzeichnis

1  .Denning D W : State-of-the-art clinical article: Invasive Aspergillosis. Clinical Infectious Diseases, 1998; 26: 781-805.

2  . Fresenius J B G W: Beitrag zur Mykologie 3 . Frankfurt am Main , 1863 ; 81-82.

3  .Latgé JP: Aspergillus fumigatus. Clinical Microbiology Reviews, 1999; 12 (2): 310-350.

4  .Chazalet V, Debeaupuis JP, Sarfati J et al.: Molecular Typing of Environmental and Patient Isolates of Aspergillus fumigatus from Various Hospital Settings. Journal of Clinical Microbiology, 1998; 36 (6): 1494-1500.

5  .Walsh TJ, Dixon DM: Nosocomial aspergillosis: environmental microbiology, hospital epidemiology, diagnosis and treatment. European Journal of Epidemiology, 1989; 5 (2): 131-142.

6  .Weems J J, Davis B J, Tablan O C et al.: Construction activity: an independent risk factor for invasive aspergillosis and zygomycosis in patients with hematologic malignancy. Infection Control and Hospital Epidemiology, 1987; 8 (2): 71-75.

7  .Leenders A C A P, van Belkum A, Behrendt M et al.: Density and Molecular Epidemiology of Aspergillus in Air and Relationship to Outbreaks of Aspergillus Infection. Journal of Clinical Microbiology, 1999; 37 (6): 1752-1757.

8  .Curtis L, Cali S, Conroy L et al.: Aspergillus surveillance project at a large tertiary-care hospital. Journal of Hospital Infection, 2005; 59 : 188-196.

9  .Patterson T F, Kirkpatrick W R, White M et al.: Invasive Aspergillosis, Disease Spectrum, Treatment Practices and Outcomes. MEDICINE, 2000; 79 (4): 250-260.

10  .Dixon, D M, McNeil M M, Cohen M L et al.: Fungal infections: a growing threat. Public Health Reports, 1996; 3 (111): 226-235.

11  .Wanke B, Santos Lazéra M dos, Nucci M: Fungal infections in the immunocompromised Host. Mem Inst Oswaldo Cruz, Rio de Janeiro, 2000; 95 (Suppl. I): 153-158.

12  .Stevens D A, Kan V L, Judson M A et al.: Practice Guidelines for Diseases Caused by Aspergillus. Clinical Infectious Diseases, Society of America, 2000; 30: 696-709.

13  .Van`t Hek L G, Verweij P E, Weemaes C M et al.: Successful Treatment with Voriconazol of Invasive Aspergillosis in Chronic Granulomatous Disease. American Journal of Respiratory and Critical Care Medicine, 1998; 157 : 1694-1696.

14  .Mouy R, Fischer A, Vilmer E et al.: Incidence, severity, and prevention of infections in chronic granulomatous disease. Journal of Pediatrics, 1989; 114: 555-560.

15  .Kirsten D, Rieger U, Amthor M, Magnussen H: Invasive aspergillosis in cavitary lung sarcoidosis. Pneumologie, 1992; 46 (6): 239-242.

16  .Kemper C A, Hostetler J S, Follansbee S E et al.: Ulcerative and plaquelike tracheobronchitis due to infection with Aspergillus in patients with AIDS. Clincal Infectious Diseases, 1993; 17 : 344-352.

17  .Solé A, Morant P, Salavert M et al.: Aspergillus infections in lung transplant recipients: risk factors and outcome. Clinical Microbiology & Infection, 2005; 11 (5): 359-365.

18  .Kramer M R, Denning D W, Marshall S E et al.: Ulcerative tracheobronchitis following lung transplantation: a new form of invasive aspergillosis. American Review of Respiratory Disease, 1991 ; 144 : 522-526.

19  .Drakos P E, Nagler A, Or R et al.: Invasive fungal sinusitis in patients undergoing bone marrow transplantation. Bone Marrow Transplantation, 1993; 12 (3): 203-208.

20  .Polzehl D, weschta m, Podbielski A et al.: Fungus culture and PCR in nasal lavage samples of patients with chronic rhinosinusitis. Journal of Medical Micribiology, 2005; 54 : 31-37.

21  .Denning D W: Therapeutic outcome in invasive aspergillosis. Clinical Infectious Diseases, 1996; 23: 608-615.

22  .Groll A H, Shah P M, Mentzel et al.: Trends in the Postmortem Epidemiology of Invasive Fungal Infections at a university hospital. Journal of Infection,1996; 33 (1): 23-32.

23  .Wald A, Leisenring W, van Burik JA, Bowden RA: Epidemiology of Aspergillus infections in a large cohort of patients undergoing bone marrow transplantation. Journal of Infectious Diseases, 1997, 175 (6): 1459-1466.

24  .Hunter A, Haynes A, Russell N: Bone marrow transplantation: current situation, complications and prevention. Journal of Antimicrobial Chemotherapy, 1995; 36 (Suppl. B): 119-133.

25  .Fishman, J A, Rubin R H: Infection in Organ-Transplant Recipients. The New England Journal of Medicine 1998; 338 : 1741-1751.

26  .Bow E J, Loewen R, Cheang M S, Schacter B: Invasive fungal disease in adults undergoing remission-induction therapy for acute myeloid leukemia: the pathogenetic role of the antileukemic regimen. Clinical Infectious Diseases, 1995; 21 (2): 361-369.

27  .Einsele H, Quabeck K, Muller K D et al.: Prediction of invasive pulmonary aspergillosis from colonisation of lower respiratory tract before marrow transplantation. Lancet, 1998; 352 (9138): 1443.

28  .Von Eiff M, Roos N, Schulten R et al.: Pulmonary aspergillosis: early diagnosis improves survival. Respiration, 1995; 62 (6): 341-347.

29  .Aisner J, Wiernik P H, Schimpff S C: Treatment of invasive aspergillosis: relation of early diagnosis and treatment to response. Annals of Internal Medicine, 1977; 86 (6): 539-543.

30  .Kontoyiannis D P, Bodey G P: Invasive Aspergillosis in 2002: an update. European Journal of Clinical Microbiology & Infectious Diseases, 2002; 21 (3): 161-172.

31  .Caillot D, Casanovas O, Bernard A et al.: Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery. Journal of Clinical Oncology, 1997; 15: 139-147.

32  .Maschmeyer G, Link H, Hiddemann W et al.: Pulmonary Infiltrations in Febrile Patients with Neutropenia. Cancer, 1994; 73 (9): 2296-2304.

33  .Diederich S, Scadeng M, Dennis C et al.: Aspergillus infection of the respiratory tract after lung transplantation: chest radiographic and CT findings. Eur. Radiol, 1998; 8 (2): 306-312.

34  .Heussel C P, Ullmann A J, Kauczor HU: Pilzpneumonie. Radiologe, 2000; 40: 518-529.

35  .Ascioglu S, Rex J H, de Pauw B et al.: Definig Opportunistic Invasive Fungal Infections in Immunocompromised Patients with Cancer and Hematopoietic Stem Cell Transplants: An International Consensus. Clinical Infectious Diseases, 2002; 34: 7-14.

36  .Seyfahrt HJ, Nenoff P, Winkler J et al.: Invasive Pulmonale Aspergillose – CT-Befunde im Kontext des klinischen Verlaufes. Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren, 2002, 174: 1115-1120.

37  .Loeffler J, Kloepfer K, Hebart H et al.: Polymerase Chain Reaction Detection of Aspergillus DNA in Experimental Models of Invasive Aspergillosis. The Journal of Infectious Diseases, 2002; 185: 1203-1206.

38  .Rimek D, Garg A P, Kappe R, Sonntag H G: Pilz-Nukleinsäure-Nachweis bei invasiven Aspergillosen. Mycoses 1998; 41 (Suppl.2): 65-68.

39  . Einsele H, Bertz H, Beyer J et al.: Epidemiologie und interventionelle Therapiestrategien infektiöser Komplikationen nach allogener Stammzelltransplantation. Deutsche Medizinische Wochenschrift, 2001; 1278-1284.

40  . Reimer L G, Wilson M L, Weinstein M P: Update on Detection of Bacteremia and Fungemia. Clinical Microbiology Reviews, 1997; 10 (3): 444-465.

41  .Maertens J, Verhaegen J, Demuynck H et al.: Autopsy-Controlled Prospective Evaluation of Serial Screening for Circulating Galactomannan by a Sandwich Enzyme-Linked Immunosorbent Assay for Hematological Patients at Risk for Invasive Aspergillosis. Journal of Clinical Microbiology, 1999; 37 (10): 3223-3228.

42  .Sanguinetti M, Posteraro B, Pagano L et al.: Comparison of Real-Time PCR, Conventional PCR, and Galactomannan Antigen Detection by Enzyme-Linked Immunosorbent Assay Using Bronchoalveolar Lavage Fluid Samples from Hematology Patients for Diagnosis of Invasive Pulmonary Aspergillosis. Journal of Clinical Microbiology, 2003; 41 (8): 3922-3925.

43  .Maertens J, Verhaegen J, Lagrou K et al.: Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: aprospective validation. Blood, 2001; 97: 1604-1610.

44  .Herbrecht R, Letscher-Bru V, Oprea C et al.: Aspergillus galactomannan detection in the diagnosis of invasive aspergillosis. Journal of Clinical Oncology, 2002; 20 (7): 1898-1906.

45  .Musher B, Fredricks D, Leisenring W et al.: Aspergillus Galactomannan Enzyme Immunoassay and Quantitative PCR for Diagnosis of Invasive Aspergillosis with Bronchoalveolar Lavage Fluid. Journal of Clinical Microbiology, 2004; 42 (12): 5517-5522.

46  .Becker M J, de Marie S, Willemse D et al.: Quantitative Galactomannan Detection Is Superior to PCR in Diagnosing and Monitoring Invasive Pulmonary Aspergillosis in an Experimental Rat Model. Journal of Clinical Microbiology, 2000; 38 (4): 1434-1438.

47  .Van Burik JA, Myerson D, Schreckhise R W et al.: Panfungal PCR Assay for Detection of Fungal Infection in Human Blood Specimens. Journal of Clinical Microbiology, 1998; 36 (5): 1169-1175.

48  .Hopfer R L, Walden P, Setterquist S, Highsmith W E: Detection and differentiation of fungi in clinical specimens using polymerase chain reaction (PCR) amplification and restriction enzyme analysis. Journal of Medical and Veterinary Mycology, 1993; 31: 65-75.

49  .Makimura K, Murayama S Y, Yamaguchi H: Detection of a wide range of medically important fungi by the polymerase chain reaction. Journal of Medical Microbioloy, 1994; 40: 358-364.

50  .Sandhu G S, Kline B C, Stockmann L, Roberts G D: Molecular Probes for Diagnosis of Fungal Infections. Journal of Clinical Microbiology, 1995; 33 (11): 2913-2919.

51  .Melchers W J G, Verweij P E, van den Hurk P et al.: General Primer-Mediated PCR for Detection of Aspergillus Species. Journal of Clinical Microbiology, 1994; 32 (7): 1710-1717.

52  .Reddy L V, Kumar A, Kurup V P: Specific amplification of Aspergillus fumigatus DNA by polymerase chain reaction. Molecular and Cellular Probes, 1993; 7: 121-126.

53  . Skladny H, Buchheidt D, Baust C et al.: Specific Detection of Aspergillus Species in Blood and Bronchoalveolar Lavage Samples of Immunocompromised Patients by Two-Step PCR. Journal of Clinical Microbiology, 1999; 37 (12): 3865-3871.

54  .Lee L G, Connell C R, Bloch W: Allelic discrimination by nick-translation PCR with fluorogenic probes. Nucleic Acids Research, 1993; 21 (16): 3761-3766.

55  .Loeffler J, Hebart H, Schumacher U et al.: Comparison of Different Methods for Extraction of DNA of Fungal Pathogens from Cultures and Blood. Journal of Clinical Microbiology, 1997; 35 (12): 3311-3312.

56  .Müller FM C, Werner K E, Kasai M et al.: Rapid Extraction of Genomic DNA from Medically Important Yeasts and Filamentous Fungi by High-Speed Cell Disruption. Journal of Clinical Microbiology, 1998; 36 (6): 1625-1629.

57  . Förster V T: Zwischenmolekulare Energiewanderung und Fluoreszenz. Anals of Physics, 1948; 2: 55-75.

58  .Livak K J, Flood S J A, Marmaro J et al.: Oligonucleotides with Fluorescent Dyes at Opposite Ends Provide a Quenched Probe System Useful for Detecting PCR Product and Nucleic Acid Hybridization. PCR Methods and Applications, 1995; 4: 357-367.

59  .Schild T A: Einführung in die Realtime-TaqMan-PCR-Technologie; 1996: 1-39.

60  .Subirà M, Martino R, Rovira M et al.: Clinical applicability of the new EORTC/MSG classification for invasive pulmonary aspergillosis in patients with hematological malignancies and autopsy-confirmed invasive aspergillosis. Ann Hematology, 2003; 82: 80-82.

61  .Haynes K, Westerneng T, Fell J, Moens W: Rapid detection and identification of pathogenic fungi by polymerase chain reaction amplification of large subunit ribosomal DNA. Journal of Medical Veterinary Mycology, 1996; 33: 319-325.

62  .Einsele H, Hebart H, Roller G et al.: Detection and Identification of Fungal Pathogens in Blood by Using Molecular Probes. Journal of Clinical Microbiology, 1997; 35 (6): 1353-1360.

63  .Williamson E C M, Leeming J P, Palmer H M et al.: Diagnosis of invasive aspergillosis in bone marrow transplant recipients by polymerase chaim reaction. British Journal of Haematology, 2000; 108: 132-139.

64  .Loeffler J, Hebart H, Bialek R et al.: Contaminations Occurring in Fungal PCR Assays. Journal of Clinical Microbiology, 1999; 37 (4): 1200-1202.

65  .Hayette MP, Vaira D, Susin F et al.: Detection of Aspergillus Species DNA by PCR in Bronchoalveolar Lavage Fluid. Journal of Clinical Microbiology, 2001; 38 (6): 2338-2340.

66  .Tang C M, Holden D, Aufauvre-Brown A, Cohen J: The Detection of Aspergillus spp. By the Polymerase Chain Reaction and Its Evaluation in Bonchoalveolar Lavage Fluid. Amreican Review of Respiratory Disease, 1993; 148: 1313-1317.

67  .Yamakami Y, Hashimoto A, Tokimatsu I, Nasu M: PCR Detection of DNA Specific for Aspergillus Species i Serum of Patients with Invasive Aspergillosis. Journal of Clinical Microbiology, 1996; 34 (10): 2464-2468.

68  .Loeffler J, Henke N, Hebart H et al.: Quantification of Fungal DNA by Using Fluorescence Resonance Energy Transfer and the Light Cycler System. Journal of Clinical Microbiology, 2000; 38 (2): 586-590.

69  .Loeffler J, Schmidt K, Hebart H et al.: Automated Extraction of Genomic DANN from Medically Important Yeast Spezies and Filamentous Fungi by Using the MagNA Pure LC System. Journal of Clinical Microbiology, 2002; 40 (6): 2240-2243.

70  .Bowman J C, Abruzzo G K, Anderson J W et al.: Quantitative PCR Assay To Measure Aspergillus fumigatus Burden in a Murine Model of Disseminated Aspergillosis: Demonstration of Efficacy of Caspofungin Acetate. Anitmicrobial Agents and Chemotherapy, 2001; 45 (12): 3474-3481.

71  .Bu R, Sathiapalan R K, Ibrahim M M et al.: Monochrome LightCycler PCR assay for detection and quantification of five common species of Candida and Aspergillus. Journal of Medical Microbiology, 2005; 54: 243-248.

72  .Challier S, Boyer S, Abachin E, Berche P: Development of a Serum-Based TaqMan Real-Time PCR Assay for Diagnosis of Invasive Aspergillosis. Journal of Clinical Microbiology, 2004; 42 (2): 844-846.

73  .Costa C, Vidaud D, Olivi M et al.: Development of two real-time quantitative TaqMan PCR assays to detect circulating Aspergillus fumigatus DNA in serum. Journal of Microbiological Methods, 2001; 44: 263-269.

74  .Costa C, Costa JM, Desterke C et al.: Real-Time PCR Coupled with Automated DNA Extraktion and Detection of Galactomannan Antigen in Serum by Enzyme-Linked Immunosorbent Assay for Diagnosis of invasive Aspergillosis. Journal of Clinical Microbiology, 2002; 40 (6): 2224-2227.

75  .Kawazu M, Kanda Y, Nannya Y et al.: Prospective Comparison of the Diagnostic Potential of Real-Time PCR, Double-Sandwich Enzyme-Linked Immunosorbent Assay for Galactomannan, and a (1→3)-ß-D-Glucan Test in Weekly Screening for Invasive Aspergillosis in Patients with Hematological Disorders. Journal of Clinical Microbiology, 2004; 42 (6): 2733-2741.

76  .Rantakokko-Jalava K, Laaksonen S, Issakainen J et al.: Semiquantitative Detection by Real-Time PCR of Aspergillus fumigatus in Bronchoalveolar Lavage Fluids and Tissue Biopsy Specimens from Patients with Invasive Aspergillosis. Journal of Clinical Microbiology, 2003; 41 (9): 4304-4311.

77  .Pryce T M, Kay I D, Palldino S, Heath C H: Real-time automated polymerase chain reaction (PCR) to detect Candida albicans and Aspergillus fumigatus DNA in whole blood from high-risk patients. Diagnostic Microbiology and Infectious Disease, 2003; 47: 487-496.

78  .Brandt M E, Padhye A A, Mayer L W et al.: Utility of Random Amplified Polymorphic DNA PCR and TaqMan Automated Detection in Molecular Identification of Aspergillus fumigatus. Journal of Clinical Microbiology, 1998; 36 (7): 2057-2062.

79  .Spiess B, Buchheidt D, Baust C et al.: Development of a LightCycler PCR Assay for Detection and Quantification of Aspergillus fumigatus DNA in Clinical Samples from Neutropenic Patients. Journal of Clinical Microbiology, 2003; 41 (5): 1811-1818.

80  .Spreadbury C, Holden D, Aufauvre-Brown A et al.: Detection of Aspergillus fumigatus by Polymerase Chain Reaction. Journal of Clinical Microbiology, 1993; 31 (3): 615-621.

81  .Buchheidt D, Hummel M, Schleiermacher D et al.: Current Molecular Diagnostic Approaches to Systemic Infections with Aspergillus Species in Patients with Hematological Malignancies. Leukemia & Lymphoma, 2004; 45 (3): 463-468.

82  .Jones M E, Fox A J, Barnes A J et al.: PCR-Elisa for the early diagnosis of invasive pulmonary aspergillus infection in neutropenic patients. Journal of Clinical Pathology, 1998; 51: 652-656.

83  .Buchheidt D, Baust C, Skladny H et al.: Detection of Aspergillus Species in Blood and Bronchoalveolar Lavage Samples from Immunocompromised Patients by Means of 2-Step Polymerase Chain Reaction: Clinical Results. Clinical Infectious Diseases, 2001; 33: 428-435.

84  .Segal B H, DeCarlo E S, Kwon-Chung K J et al.: Aspergillus nidulans infection in chronic granulomatous disease. Medicine (Baltimore), 1998; 77 (5): 345-354.

85  .Verweij P E, Weemaes C M, Curfs J H A J et al.: Failure To Detect Circulating Aspergillus Markers in a Patient with Chronic Granulomatous Disease and Invasive Aspergillosis. Journal of Clinical Microbiology, 2000; 38 (10): 3900-3901.

86  .Bretagne S, Costa JM, Bart-Delabesse E et al.: Comparison of Serum Galactomannan Antigen Detection and Competetive Polymerase Chain Reaction for Diagnosing Invasive Aspergillosis. Clinical Infectious Diseases, 1998; 26: 1407-1412.

87  .Buchheidt D, Hummel M, Schleiermacher D et al.: Prospective clinical evaluation of a LightCyclerTM-mediated polymerase chain reaction assay, a nested-PCR assay and a galactomannan enzyme-linked immunosorbent assay for detection of invasive aspergillosis in neutropenic cancer patients and haematological stem cell transplant recipients. British Journal of Haematology; 125: 196-202.

88  .Hashimoto A, Yamakami Y, Kamberi P et al.: Comparison of PCR, (1→3)-ß-D-Glucan and Galactomannan Assays in Sera of Rats With Experimental Invasive Aspergillosis. Journal of Clinical Laboratory Analysis, 1998; 12: 257-262.

89  .Kawamura S, Maesaki S, Noda T et al.: Comparison between PCR and detection of antigen in sera for diagnosis of pulmonary aspergillosis. Journal of Clinical Microbiology, 1999; 37: 218-220.

90  .Verweij P E, Latgé JP, Rijs A J M M et al.: Comparison of Antigen Detection and PCR Assay Using Bronchoalveolar Lavage Fluid for Diagnosing Invasive Pulmonary Aspergillosis in Patients Receiving Treatment for Hematological Malignancies. Journal of Clinical Microbiology, 1995; 33 (12): 3150-3153.


© Die inhaltliche Zusammenstellung und Aufmachung dieser Publikation sowie die elektronische Verarbeitung sind urheberrechtlich geschützt. Jede Verwertung, die nicht ausdrücklich vom Urheberrechtsgesetz zugelassen ist, bedarf der vorherigen Zustimmung. Das gilt insbesondere für die Vervielfältigung, die Bearbeitung und Einspeicherung und Verarbeitung in elektronische Systeme.
DiML DTD Version 4.0Zertifizierter Dokumentenserver
der Humboldt-Universität zu Berlin
HTML-Version erstellt am:
06.09.2007